Tong Wang

2.1k total citations
105 papers, 1.6k citations indexed

About

Tong Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tong Wang has authored 105 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 42 papers in Cancer Research and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tong Wang's work include Cancer-related molecular mechanisms research (24 papers), RNA modifications and cancer (23 papers) and Antibiotic Resistance in Bacteria (18 papers). Tong Wang is often cited by papers focused on Cancer-related molecular mechanisms research (24 papers), RNA modifications and cancer (23 papers) and Antibiotic Resistance in Bacteria (18 papers). Tong Wang collaborates with scholars based in China, United States and United Kingdom. Tong Wang's co-authors include Renhui Shen, Longchang Huang, Haoze Shi, Hang Chen, Yue Deng, Jianxin Tao, Yu Wang, Xingli Guo, David Chiu and Luxia Song and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Tong Wang

94 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tong Wang China 20 873 637 282 240 142 105 1.6k
Rui Zheng China 22 808 0.9× 510 0.8× 134 0.5× 136 0.6× 110 0.8× 81 1.4k
Yanyong Yang China 24 657 0.8× 359 0.6× 198 0.7× 222 0.9× 190 1.3× 69 1.7k
Xiaojiao Zhang China 22 603 0.7× 324 0.5× 133 0.5× 78 0.3× 110 0.8× 81 1.2k
Zhiqiang Qin China 21 681 0.8× 391 0.6× 49 0.2× 242 1.0× 106 0.7× 70 1.3k
Philip Warburton United Kingdom 21 688 0.8× 157 0.2× 109 0.4× 81 0.3× 115 0.8× 42 1.3k
Naoko Yokota Japan 20 634 0.7× 164 0.3× 86 0.3× 121 0.5× 104 0.7× 43 1.6k
Xiong Liu China 26 1.3k 1.5× 1.1k 1.7× 87 0.3× 138 0.6× 427 3.0× 92 2.3k
Lingyun Guo China 18 401 0.5× 113 0.2× 95 0.3× 134 0.6× 128 0.9× 79 982
Santiago Redondo Spain 23 548 0.6× 83 0.1× 310 1.1× 51 0.2× 92 0.6× 43 1.3k

Countries citing papers authored by Tong Wang

Since Specialization
Citations

This map shows the geographic impact of Tong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tong Wang more than expected).

Fields of papers citing papers by Tong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tong Wang. The network helps show where Tong Wang may publish in the future.

Co-authorship network of co-authors of Tong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Tong Wang. A scholar is included among the top collaborators of Tong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tong Wang. Tong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, He, Liang Li, Tong Wang, et al.. (2025). DDIT4 knockdown suppresses venous malformation progression by inhibiting NF-κB signaling as a potential therapeutic target. Microvascular Research. 161. 104833–104833.
4.
Zhuo, Chao, Wei Kang, Qiwen Yang, et al.. (2024). Establishment of epidemiological cut-off values for eravacycline, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Acinetobacter baumannii and Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 79(9). 2246–2250. 6 indexed citations
5.
Wang, Jinsong, Jia Feng, Xinyi Chen, et al.. (2024). Integrated multi-omics analysis and machine learning identify hub genes and potential mechanisms of resistance to immunotherapy in gastric cancer. Aging. 16(8). 7331–7356. 6 indexed citations
6.
Wu, Junzheng, Jianzhang Wang, Tong Wang, et al.. (2024). Isorhamnetin inhibits hypertrophic scar formation through TGF-β1/Smad and TGF-β1/CREB3L1 signaling pathways. Heliyon. 10(13). e33802–e33802. 6 indexed citations
7.
Li, Yun, Wenwen Cui, Zhongfa Yang, et al.. (2024). Influence of <italic>GPRC5A</italic>-Regulated <italic>ABCB1</italic> Expression on Lung Adenocarcinoma Proliferation. Chinese Medical Sciences Journal. 39(1). 9–18. 1 indexed citations
9.
Wang, Tao, Shuo Chen, Ziliang Wang, et al.. (2023). KIRREL promotes the proliferation of gastric cancer cells and angiogenesis through the PI3K/AKT/mTOR pathway. Journal of Cellular and Molecular Medicine. 28(1). e18020–e18020. 7 indexed citations
10.
Liu, Qiao, Mengzi Sun, Tong Wang, et al.. (2023). The Differential Antagonistic Ability of Curcumin against Cytotoxicity and Genotoxicity Induced by Distinct Heavy Metals. Toxics. 11(3). 233–233. 7 indexed citations
11.
Wang, Tong, et al.. (2023). Molecular characterization of class 1 integrons in carbapenem-resistant Enterobacterales isolates. Microbial Pathogenesis. 177. 106051–106051. 9 indexed citations
12.
Wang, Xiaoxue, Lulu Zhang, Tong Wang, et al.. (2023). [Prognostic Value of CD56 Expression in Newly Diagnosed Multiple Myeloma Patients and Its Related Factors].. PubMed. 31(3). 777–782.
13.
Wang, Tong, Mengzi Sun, Han Li, et al.. (2023). Pulmonary flora-modified diesel particulate matter induced lung injury via cGAS signaling pathway. The Science of The Total Environment. 892. 164490–164490. 3 indexed citations
14.
Wang, Jinsong, Yiming Weng, Xinyi Chen, et al.. (2023). Application of an angiogenesis-related genes risk model in lung adenocarcinoma prognosis and immunotherapy. Frontiers in Genetics. 14. 1092968–1092968. 4 indexed citations
15.
Gao, Haotian, et al.. (2023). Design, Synthesis, and Biological Evaluation of Sulfonamide Methoxypyridine Derivatives as Novel PI3K/mTOR Dual Inhibitors. Pharmaceuticals. 16(3). 461–461. 13 indexed citations
17.
Zhang, Jie, Luxia Song, Liyan Xu, et al.. (2021). Knowledge Domain and Emerging Trends in Ferroptosis Research: A Bibliometric and Knowledge-Map Analysis. Frontiers in Oncology. 11. 686726–686726. 126 indexed citations
18.
Guo, Si, Na Wei, Rui Xue, et al.. (2020). ciRS‐7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR‐7/Epidermal Growth Factor Receptor Axis. BioMed Research International. 2020(1). 9875636–9875636. 27 indexed citations
19.
Yan, Xuebo, Tong Wang, & Jiong Wang. (2020). Circ_0016760 Acts as a Sponge of MicroRNA-4295 to Enhance E2F Transcription Factor 3 Expression and Facilitates Cell Proliferation and Glycolysis in Non-Small Cell Lung Cancer. Cancer Biotherapy and Radiopharmaceuticals. 37(2). 147–158. 15 indexed citations
20.
Wang, Tong, et al.. (2011). The Risk Factors and Prognosis of Bilateral Primary Breast Cancer: A Comparative Study With Unilateral Breast Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 19(3). 171–178. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026